TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice
eLife · 2023
DOI: 10.7554/elife.83451 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Yuanyuan Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Genentech Inc, South San Francisco, United States. Hauptthemen laut MEDLINE: MAP Kinase Kinase Kinases, Tauopathies. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tumor progression locus 2 (TPL2) (MAP3K8) is a central signaling node in the inflammatory response of peripheral immune cells. We find that TPL2 kinase activity modulates microglial cytokine release and is required for microglia-mediated neuron death in vitro. In acute in vivo neuroinflammation settings, TPL2 kinase activity regulates microglia activation states and brain cytokine levels. In a tauopathy model of chronic neurodegeneration, loss of TPL2 kinase activity reduces neuroinflammation and rescues synapse loss, brain volume loss, and behavioral deficits. Single-cell RNA sequencing analysis indicates that protection in the tauopathy model was associated with reductions in activated microglia subpopulations as well as infiltrating peripheral immune cells. Overall, using various models, we find that TPL2 kinase activity can promote multiple harmful consequences of microglial activation in the brain including cytokine release, iNOS (inducible nitric oxide synthase) induction, astrocyte activation, and immune cell infiltration. Consequently, inhibiting TPL2 kinase activity could represent a potential therapeutic strategy in neurodegenerative conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Genentech Inc, South San Francisco, United States.
- Department of OMNI Bioinformatics, Genentech Inc, South San Francisco, United States.
- Computational Science & Exploratory Analytics, Roche IT, Hoffmann-La Roche Limited, Mississauga, Canada.
- Department of Translational Imaging, Genentech Inc, South San Francisco, United States.
- Department of Pathology, Genentech Inc, South San Francisco, United States.
- Department of Immunology, Genentech Inc, South San Francisco, United States.
ORCID-Profile: Yuanyuan Wang, Tiffany Wu, Jesse E Hanson
Zitieren
APA
Wang, Y., Wu, T., Tsai, M. C., Rezzonico, M. G., Abdel-Haleem, A. M., Xie, L., Gandham, V. D., Ngu, H., Stark, K., Glock, C., Xu, D., Foreman, O., Friedman, B. A., Sheng, M., & Hanson, J. E. (2023). TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice. eLife. https://doi.org/10.7554/elife.83451
Vancouver
Wang Y, Wu T, Tsai MC, Rezzonico MG, Abdel-Haleem AM, Xie L, et al. TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice. eLife. 2023. doi:10.7554/elife.83451
BibTeX
@article{Wang2023,
author = {Wang, Yuanyuan and Wu, Tiffany and Tsai, Ming-Chi and Rezzonico, Mitchell G and Abdel-Haleem, Alyaa M and Xie, Luke and Gandham, Vineela D and Ngu, Hai and Stark, Kimberly and Glock, Caspar and Xu, Daqi and Foreman, Oded and Friedman, Brad A and Sheng, Morgan and Hanson, Jesse E},
title = {TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.83451}
}
EUVIMED